The investigation of neuropsychiatric symptoms of dementia by the molecular neuroimaging
Not Applicable
- Conditions
- Alzheimer's disease, Dementia with Lewy bodies
- Registration Number
- JPRN-UMIN000024991
- Lead Sponsor
- ara medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. A history of head injury 2. A diagnose of abuse or addiction of drugs 3. A diagnose or history of mental illness based on DSM-5 and neurological illness other than Alzheimer's disease or dementia with Lewy bodies for Dementia patients group 4. No consent ability
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We investigate the relationships between neuropsychiatric symptoms and MRI, SPECT, and neuropsychological tests in clinical use.
- Secondary Outcome Measures
Name Time Method We investigate neuropsychiatric symptoms and MRI, SPECT, and neuropsychological tests of control subjects, for comparing with dementia patients.